Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CENTENE CORPORATION

(CNC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Centene : Morgan Stanley Adjusts Centene's Price Target to $79 from $88, Keeps Overweight Rating

09/14/2021 | 12:00pm EDT


ę MT Newswires 2021
All news about CENTENE CORPORATION
10/08CENTENE : David Steward Retires From Centene's Board Of Directors
PR
10/08Centene Corporation Announces Retirement of David L. Steward from Board of Directors
CI
10/08CENTENE : DAVID STEWARD RETIRES FROM CENTENE'S BOARD OF DIRECTORS - Form 8-K
PU
10/08CENTENE CORP : Change in Directors or Principal Officers, Regulation FD Disclosure, Financ..
AQ
10/04CENTENE : to Expand Medicare Advantage Offerings 26% Next Year
MT
10/04CENTENE : Expands Medicare Advantage Offerings for 2022
PR
10/04Centene Corporation Expands Medicare Advantage Offerings for 2022
CI
09/30VC DAILY : Expansion Therapeutics Gets $80 Million for RNA-Targeted Drugs
DJ
09/29CENTENE : U.S. Medical Management Accountable Care Partners (ACO) Improves Quality of Care..
PR
09/28Axial Healthcare, Inc. announced that it has received $75 million in funding from a gro..
CI
More news
Analyst Recommendations on CENTENE CORPORATION
More recommendations
Financials (USD)
Sales 2021 125 B - -
Net income 2021 1 185 M - -
Net Debt 2021 9 280 M - -
P/E ratio 2021 32,6x
Yield 2021 -
Capitalization 38 084 M 38 084 M -
EV / Sales 2021 0,38x
EV / Sales 2022 0,37x
Nbr of Employees 71 300
Free-Float 96,0%
Chart CENTENE CORPORATION
Duration : Period :
Centene Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CENTENE CORPORATION
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 19
Last Close Price 65,32 $
Average target price 83,79 $
Spread / Average Target 28,3%
EPS Revisions
Managers and Directors
Michael F. Neidorff Chairman & Chief Executive Officer
Brent Davis Layton President & Chief Operating Officer
Andrew Lynn Asher Chief Financial Officer & Executive Vice President
Mary V. Mason Chief Medial Officer & Senior Vice President
Ken Yamaguchi Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capi. (M$)
CENTENE CORPORATION8.81%38 084
UNITEDHEALTH GROUP19.87%403 635
ANTHEM, INC.21.68%95 832
CIGNA CORPORATION-2.47%70 127
HUMANA INC.6.02%56 671
MOLINA HEALTHCARE, INC.31.70%16 357